|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom | Spelman, T.; Herring, W. L.; Acosta, C.; Hyde, R.; Jokubaitis, V. G.; Pucci, E.; Lugaresi, A.; Laureys, G.; Havrdova, E. K.; Horakova, D.; Izquierdo, G.; Eichau, S.; Ozakbas, S.; Alroughani, R.; Kalincik, T.; Duquette, P.; Girard, M.; Petersen, T.; Patti, F.; Csepany, T.; Granella, F.; Grand'Maison, F.; Ferraro, D.; Karabudak, R.; Jose Sa, M.; Trojano, M.; van Pesch, V.; VAN WIJMEERSCH, Bart; Cartechini, E.; Mccombe, P.; Gerlach, O.; Spitaleri, D.; Rozsa, C.; Hodgkinson, S.; Bergamaschi, R.; Gouider, R.; Soysal, A.; Prevost, J.; Garber, J.; de Gans, K.; Ampapa, R.; Simo, M.; Sanchez-Menoyo, J. L.; Iuliano, G.; Sas, A.; van der Walt, A.; John, N.; Gray, O.; Hughes, S.; De Luca, G.; Onofrj, M.; Buzzard, K.; Skibina, O.; Terzi, M.; Slee, M.; Solaro, C.; Ramo-Tello, C.; Fragoso, Y.; Shaygannejad, V.; Moore, F.; Rajda, C.; Aguera Morales, E.; Butzkueven, H. | Journal Contribution | A1 |
| 2 | 2024 | Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab | BECKERS, Lien; BAETEN, Paulien; POPESCU, Veronica; SWINNEN, Dries; CARDILLI, Alessio; HAMAD, Ibrahim; VAN WIJMEERSCH, Bart; Tavernier, S.J.; KLEINEWIETFELD, Markus; BROUX, Bieke; FRAUSSEN, Judith; SOMERS, Veerle | Journal Contribution | A1 |
| 3 | 2024 | Rapamycin rescues loss of function in blood-brain barrier–interacting Tregs | BAETEN, Paulien; HAMAD, Ibrahim; HOEKS, Cindy; Hiltensperger, Michael; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Aly, Lilian; SOMERS, Veerle; Korn, Thomas; KLEINEWIETFELD, Markus; HELLINGS, Niels; BROUX, Bieke | Journal Contribution | A1 |
| 4 | 2023 | Walking to music and metronome ticks at high and low tempi in persons with progressive MS: preliminary findings | VANBILSEN, Nele; MOUMDJIAN, Lousin; Moens, Bart; D'HOOGE, Mieke; KOS, Daphne; Poukens, Lotte; VAN WIJMEERSCH, Bart; Leman, Marc; FEYS, Peter | Journal Contribution | M |
| 5 | 2023 | Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies | Li , Ying; Saul, Alice; Taylor, Bruce; Ponsonby, Anne-Louise; Simpson-Yap, Steve; Blizzard, Leigh; Broadley, Simon; Lechner-Scott, Jeannette; Karabudak, Rana; Patti, Francesco; Eichau, Sara; Onofrj, Marco; Ozakbas, Serkan; Horakova, Dana; Havrdova, Eva Kubala; Grand'Maison, Francois; Alroughani, Raed; Gerlach, Oliver; Amato, Maria Pia; Altintas, Ayse; Girard, Marc; Duquette, Pierre; Blanco, Yolanda; Ramo-Tello, Cristina; Laureys, Guy; Kalincik, Tomas; Khoury, Samia J.; Shaygannejad, Vahid; Etemadifar, Masoud; Singhal, Bhim; Mrabet, Saloua; Foschi, Matteo; Habek, Mario; John, Nevin; Hughes, Stella; McCombe, Pamela; Ampapa, Radek; van der Walt, Anneke; Butzkueven, Helmut; de Gans, Koen; McGuigan, Chris; Oreja-Guevara, Celia; Sa, Maria Jose; Petersen, Thor; Al-Harbi, Talal; Sempere, Angel Perez; VAN WIJMEERSCH, Bart; Grigoriadis, Nikolaos; Prevost, Julie; Gray, Orla; Castillo-Trivino, Tamara; Macdonell, Richard; Lugaresi, Alessandra; Sajedi, Seyed Aidin; MSBase; van der Mei, Ingrid | Journal Contribution | A1 |
| 6 | 2023 | Disability accrual in primary and secondary progressive multiple sclerosis | Harding-Forrester, Sam; Roos, Izanne; Nguyen, Ai-Lan; Malpas, Charles B.; Diouf, Ibrahima; Moradi, Nahid; Sharmin , Sifat; Izquierdo, Guillermo; Eichau, Sara; Patti, Francesco; Horakova, Dana; Kubala Havrdova, Eva; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Maison, Francois Grand; Onofrj, Marco; Lugaresi, Alessandra; Grammond, Pierre; Ozakbas, Serkan; Amato, Maria Pia; Gerlach, Oliver; Sola, Patrizia; Ferraro, Diana; Buzzard, Katherine; Skibina, Olga; Lechner-Scott, Jeannette; Alroughani, Raed; Boz, Cavit; Van Pesch, Vincent; Cartechini, Elisabetta; Terzi, Murat; Maimone, Davide; Ramo-Tello, Cristina; Yamout, Bassem; Khoury, Samia Joseph; La Spitaleri, Daniele; Sa, Maria Jose; Blanco, Yolanda; Granella, Franco; Slee, Mark; Butler, Ernest; Sidhom, Youssef; Gouider, Riadh; Bergamaschi, Roberto; Karabudak, Rana; Ampapa, Radek; Sanchez-Menoyo, Jose Luis; Prevost, Julie; Castillo-Trivino, Tamara; McCombe, Pamela A.; Macdonell, Richard; Laureys, Guy; Van Hijfte, Liesbeth; Oh, Jiwon; Altintas, Ayse; de Gans, Koen; Turkoglu, Recai; van der Walt, Anneke; Butzkueven, Helmut; Vucic, Steve; Barnett, Michael; Cristiano, Edgardo; Hodgkinson, Suzanne; Iuliano, Gerardo; Kappos, Ludwig; Kuhle, Jens; Shaygannejad, Vahid; Soysal, Aysun; Weinstock-Guttman, Bianca; VAN WIJMEERSCH, Bart; Kalincik, Tomas | Journal Contribution | A1 |
| 7 | 2023 | Comparative effectiveness in multiple sclerosis: A methodological comparison | Roos, Izanne; Diouf, Ibrahima; SHARMIN, Sifat; Horakova, Dana; Havrdova, Eva Kubala; Patti, Francesco; Shaygannejad, Vahid; Ozakbas, Serkan; Izquierdo, Guillermo; Eichau, Sara; Onofrj, Marco; Lugaresi, Alessandra; Alroughani, Raed; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Terzi, Murat; Boz, Cavit; Grand'Maison, Francois; Sola, Patrizia; Ferraro, Diana; Grammond, Pierre; Turkoglu, Recai; Buzzard, Katherine; Skibina, Olga; Yamou, Bassem; Altintas, Ayse; Gerlach, Oliver; van Pesch, Vincent; Blanco, Yolanda; Maimone, Davide; Lechner-Scott, Jeannette; Bergamaschi, Roberto; Karabudak, Rana; McGuigan, Chris; Cartechini, Elisabetta; Barnett, Michael; Hughes, Stella; Sa, Maria Jose; Solaro, Claudio; Ramo-Tello, Cristina; Hodgkinson, Suzanne; Spitaleri, Daniele; Soysal, Aysun; Petersen, Thor; Granella, Franco; de Gans, Koen; McCombe, Pamela; Ampapa, Radek; VAN WIJMEERSCH, Bart; van der Walt, Anneke; Butzkueven, Helmut; Prevost, Julie; Sanchez-Menoyo, Jose Luis; Laureys, Guy; Gouider, Riadh; Castillo-Trivino, Tamara; Gray, Orla; Aguera-Morales, Eduardo; Al-Asmi, Abdullah; Shaw, Cameron; Deri, Norma; Al-Harbi, Talal; Fragoso, Yara; Csepany, Tunde; Sempere, Angel Perez; Trevino-Frenk, Irene; Schepel, Jan; Moore, Fraser; Malpas, Charles; Kalincik, Tomas | Journal Contribution | A1 |
| 8 | 2023 | Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation | Zhu, Chao; Kalincik, Tomas; Horakova, Dana; Zhou, Zhen; Buzzard, Katherine; Skibina, Olga; Alroughani, Raed; Izquierdo, Guillermo; Eichau, Sara; Kuhle, Jens; Patti, Francesco; Grand'Maison, Francois; Hodgkinson, Suzanne; Grammond, Pierre; Lechner-Scott, Jeannette; Butler, Ernest; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Macdonell, Richard A. L.; Weinstock-Guttman, Bianca; Ozakbas, Serkan; Slee, Mark; Sa, Maria Jose; Van Pesch, Vincent; Barnett, Michael; VAN WIJMEERSCH, Bart; Gerlach, Oliver; Prevost, Julie; Terzi, Murat; Boz, Cavit; Laureys, Guy; Van Hijfte, Liesbeth; Kermode, Allan G.; Garber, Justin; Yamout, Bassem; Khoury, Samia J.; Merlo, Daniel; Monif, Mastura; Jokubaitis, Vilija; van der Walt, Anneke; Butzkueven, Helmut; MSBase Study Grp | Journal Contribution | A1 |
| 9 | 2023 | Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies | Dayan, Colin M.; Lecumberri, Beatriz; Muller, Ilaria; Ganesananthan, Sashiananthan; Hunter, Samuel F.; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Havrdova, Eva K.; LaGanke, Christopher C.; Ziemssen, Tjalf; VAN WIJMEERSCH, Bart; Meuth, Sven G.; Margolin, David H.; Poole, Elizabeth M.; Baker, Darren P.; Senior, Peter A. | Journal Contribution | A1 |
| 10 | 2023 | The risk of secondary progressive multiple sclerosis is geographically determined but modifiable | Sharmin , Sifat; Roos, Izanne; Simpson-Yap, Steve; Malpes, Charles; Sanchez, Marina M.; Ozakbas, Serkan; Horakova, Dana; Havrdova, Eva K.; Patti, Francesco; Alroughani, Raed; Izquierdo, Guillermo; Eichau, Sara; Boz, Cavit; Zakaria, Magd; Onofrj, Marco; Lugaresi, Alessandra; Weinstock-Guttman, Bianca; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Terzi, Murat; Amato, Maria Pia; Karabudak, Rana; Grand'Maison, Francois; Khoury, Samia J.; Grammond, Pierre; Lechner-Scott, Jeannette; Buzzard, Katherine; Skibina, Olga; van der Walt, Anneke; Butzkueven, Helmut; Turkoglu, Recai; Altintas, Ayse; Maimone, Davide; Kermode, Allan; Shalaby, Nevin; Pesch, Vincent V.; Butler, Ernest; Sidhom, Youssef; Gouider, Riadh; Mrabet, Saloua; Gerlach, Oliver; Soysal, Aysun; Barnett, Michael; Kuhle, Jens; Hughes, Stella; Sa, Maria J.; Hodgkinson, Suzanne; Oreja-Guevara, Celia; Ampapa, Radek; Petersen, Thor; Ramo-Tello, Cristina; Spitaleri, Daniele; McCombe, Pamela; Taylor, Bruce; Prevost, Julie; Foschi, Matteo; Slee, Mark; McGuigan, Chris; Laureys, Guy; Hijfte, Liesbeth V.; de Gans, Koen; Solaro, Claudio; Oh, Jiwon; Macdonell, Richard; Aguera-Morales, Eduardo; Singhal, Bhim; Gray, Orla; Garber, Justin; VAN WIJMEERSCH, Bart; Simu, Mihaela; Castillo-Trivino, Tamara; Sanchez-Menoyo, Jose L.; Khurana, Dheeraj; Al-Asmi, Abdullah; Al-Harbi, Talal; Deri, Norma; Fragoso, Yara; Lalive, Patrice H.; Sinnige, L. G. F.; Shaw, Cameron; Shuey, Neil; Csepany, Tunde; Sempere, Angel P.; Moore, Fraser; Decoo, Danny; Willekens, Barbara; Gobbi, Claudio; Massey, Jennifer; Hardy, Todd; Parratt, John; Kalincik, Tomas | Journal Contribution | A1 |
| 11 | 2023 | Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis | Diouf, Ibrahima; Malpas, Charles B.; Sharmin , Sifat; Roos, Izanne; Horakova, Dana; Havrdova, Eva Kubala; Patti, Francesco; Shaygannejad, Vahid; Ozakbas, Serkan; Izquierdo, Guillermo; Eichau, Sara; Onofrj, Marco; Lugaresi, Alessandra; Alroughani, Raed; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Terzi, Murat; Boz, Cavit; Grand'Maison, Francois; Hamdy, Sherif; Sola, Patrizia; Ferraro, Diana; Grammond, Pierre; Turkoglu, Recai; Buzzard, Katherine; Skibina, Olga; Yamout, Bassem; Altintas, Ayse; Gerlach, Oliver; van Pesch, Vincent; Blanco, Yolanda; Maimone, Davide; Lechner-Scott, Jeannette; Bergamaschi, Roberto; Karabudak, Rana; Iuliano, Gerardo; McGuigan, Chris; Cartechini, Elisabetta; Barnett, Michael; Hughes, Stella; Sa, Maria Jose; Solaro, Claudio; Kappos, Ludwig; Ramo-Tello, Cristina; Cristiano, Edgardo; Hodgkinson, Suzanne; Spitaleri, Daniele; Soysal, Aysun; Petersen, Thor; Slee, Mark; Butler, Ernest; Granella, Franco; de Gans, Koen; McCombe, Pamela; Ampapa, Radek; VAN WIJMEERSCH, Bart; van der Walt, Anneke; Butzkueven, Helmut; Prevost, Julie; Sinnige, L. G. F.; Sanchez-Menoyo, Jose Luis; Vucic, Steve; Laureys, Guy; Van Hijfte, Liesbeth; Khurana, Dheeraj; Macdonell, Richard; Gouider, Riadh; Castillo-Trivino, Tamara; Gray, Orla; Aguera-Morales, Eduardo; Al-Asmi, Abdullah; Shaw, Cameron; Deri, Norma; Al-Harbi, Talal; Fragoso, Yara; Csepany, Tunde; Sempere, Angel Perez; Trevino-Frenk, Irene; Schepel, Jan; Moore, Fraser; Kalincik, Tomas | Journal Contribution | A1 |
| 12 | 2023 | Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis | Daruwalla, Cyrus; Shaygannejad, Vahid; Ozakbas, Serkan; Havrdova, Eva Kubala; Horakova, Dana; Alroughani, Raed; Boz, Cavit; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Eichau, Sara; Girard, Marc; Prat, Alexandre; Duquette, Pierre; Yamout, Bassem; Khoury, Samia J.; Sajedi, Seyed Aidin; Turkoglu, Recai; Altintas, Ayse; Skibina, Olga; Buzzard, Katherine; Grammond, Pierre; Karabudak, Rana; van der Walt, Anneke; Butzkueven, Helmut; Maimone, Davide; Lechner-Scott, Jeannette; Soysal, Aysun; John, Nevin; Prevost, Julie; Spitaleri, Daniele; Ramo-Tello, Cristina; Gerlach, Oliver; Iuliano, Gerardo; Foschi, Matteo; Ampapa, Radek; van Pesch, Vincent; Barnett, Michael; Shalaby, Nevin; D'hooghe, Marie; Kuhle, Jens; Sa, Maria Jose; Fabis-Pedrini, Marzena; Kermode, Allan; Mrabet, Saloua; Gouider, Riadh; Hodgkinson, Suzanne; Laureys, Guy; Van Hijfte, Liesbeth; Macdonell, Richard; Oreja-Guevara, Celia; Cristiano, Edgardo; McCombe, Pamela; Sanchez-Menoyo, Jose Luis; Singhal, Bhim; Blanco, Yolanda; Hughes, Stella; Garber, Justin; Solaro, Claudio; McGuigan, Chris; Taylor, Bruce; de Gans, Koen; Habek, Mario; Al-Asmi, Abdullah; Mihaela, Simu; Castillo Trivino, Tamara; Al-Harbi, Talal; Rojas, Juan Ignacio; Gray, Orla; Khurana, Dheeraj; VAN WIJMEERSCH, Bart; Grigoriadis, Nikolaos; Inshasi, Jihad; Oh, Jiwon; Aguera-Morales, Eduardo; Fragoso, Yara; Moore, Fraser; Shaw, Cameron; Baghbanian, Seyed Mohammad; Shuey, Neil; Willekens, Barbara; Hardy, Todd A.; Decoo, Danny; Sempere, Angel Perez; Field, Deborah; Wynford-Thomas, Ray; Cunniffe, Nick G.; Roos, Izanne; Malpas, Charles B.; Coles, Alasdair J.; Kalincik, Tomas; Brown, J. William L.; MSBase Study Grp | Journal Contribution | A1 |
| 13 | 2023 | Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence | Oreja-Guevara, Celia; Brownlee, Wallace; Celius, Elisabeth G.; Centonze, Diego; Giovannoni, Gavin; Hodgkinson, Suzanne; Kleinschnitz, Christoph; Kubala Havrdova, Eva; Magyari, Melinda; Selchen, Daniel; Vermersch, Patrick; Wiendl, Heinz; VAN WIJMEERSCH, Bart; Salloukh, Hashem; Yamout, Bassem | Journal Contribution | A1 |
| 14 | 2023 | Effect of high-efficacy therapy on the course of disability in paediatric-onset multiple sclerosis | Sharmin , Sifat; Roos, Izanne; Malpas, Charles; Horakova, Dana; Havrdova, Eva; Ozakbas, Serkan; Alroughani, Raed; Patti, Francesco; Izquierdo, Guillermo; Madueno, Sara Eichau; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Yammout, Bassem; Khoury, Samia; Lugaresi, Alessandra; Onofrj, Marco; Terzi, Murat; Shaygannejad, Vahid; Grammond, Pierre; Sa, Maria Jose; Lechner-Scott, Jeannette; Buzzard, Katherine; Skibina, Olga; Gouider, Riadh; Mrabet, Saloua; John, Nevin; Cartechini, Elisabetta; Weinstock-Guttman, Bianca; van der Walt, Anneke; Butzkueven, Helmut; Kuhle, Jens; Laureys, Guy; Van Hijfte, Liesbeth; Maimone, Davide; Blanco, Yolanda; Rio, Maria; Turkoglu, Recai; D'hooghe, Marie; Van Pesch, Vincent; Bolanos, Ricardo; Spitaleri, Daniele L. A.; Gerlach, O.; Prevost, Julie; Ampapa, Radek; Soysal, Aysun; Altintas, Ayse; Zamzam, Dina; Solaro, Claudio Marcello; Foschi, Matteo; VAN WIJMEERSCH, Bart; Morales, Eduardo Aguera; Barnett, Michael; Oh, Jiwon; Tello, Cristina Ramo; Sanchez, Jose Luis; Al Harbi, Talal Muteb; Iaffaldano, Pietro; Filippi, Massimo; Simone, Marta; Morra, Vincenzo Brescia; Cocco, Eleonora; Pozzilli, Carlo; De Luca, Giovanna; Ferraro, Diana; Gallo, Paolo; Gasperini, Claudio; Lus, Giacomo; Bergamaschi, Roberto; Totaro, Rocco; Zaffaroni, Mauro; Romano, Silvia; Vianello, Marika; Banfi, Paola; Salemi, Giuseppe; Pesci, Ilaria; Aguglia, Umberto; Protti, Alessandra; Granella, Franco; Portaccio, Emilio; Coniglio, Maria Gabriella; Valentino, Paola; Di Palma, Franco; Clerici, Valentina Torri; Maniscalco, Giorgia Teresa; Vukusic, Sandra; Trojano, Maria; Amato, Maria Pia; Kalincik, Tomas | Journal Contribution | M |
| 15 | 2023 | Safety and effectiveness of cladribine tablets for multiple sclerosis: Results from a single-center real-world cohort | AERTS, Sofie; KHAN, Hamza; SEVERIJNS, Deborah; POPESCU, Veronica; PEETERS, Liesbet; VAN WIJMEERSCH, Bart | Journal Contribution | A1 |
| 16 | 2023 | Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-centre randomised placebo controlled clinical trial | De Keersmaecker, Anna-Victoria; VAN DONINCK, Eline; Cambron, Melissa; POPESCU, Veronica; Laureys, Guy; Willem , Lander; Haeseleer, Miguel D'; Bjerke, Maria; Roelant, Ella; VAN WIJMEERSCH, Bart; D'hooghe, Marie; Derdelinckx, Judith; Reynders, Tatjana; Bossche, Stephanie Vanden; Willekens, Barbara | Journal Contribution | M |
| 17 | 2022 | Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis | Lefort, M.; Sharmin , S.; Andersen, J. B.; Vukusic, S.; Casey, R.; Debouverie, M.; Edan, G.; Ciron, J.; Ruet, A.; De Seze, J.; Maillart, E.; Zephir, H.; Labauge, P.; Defer, G.; Lebrun-Frenay, C.; Moreau, T.; Berger , E.; Clavelou, P.; Pelletier, J.; Stankoff, B.; Gout, O.; Thouvenot, E.; Heinzlef, O.; Al-Khedr, A.; Bourre, B.; Casez, O.; Cabre, P.; Montcuquet, A.; Wahab, A.; Camdessanche, J. P.; Maurousset, A.; Ben Nasr, H.; Hankiewicz, K.; Pottier, C.; Maubeuge, N.; Nifle, C.; Laplaud, D. A.; Horakova, D.; Dimitri-Boulos, D.; Havrdova, E. K.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Ozakbas, S.; Patti, F.; Onofrj, M.; Lugaresi, A.; Terzi, M.; Grammond, P.; Grand'Maison, F.; Yamout, B.; Prat, A.; Girard, M.; Duquette, P.; Boz, C.; Trojano, M.; McCombe, P.; Slee, M.; Lechner-Scott, J.; Turkoglu, R.; Sola, P.; Ferraro, D.; Granella, F.; Shaygannejad, V; Prevost, J.; Maimone, D.; Skibina, O.; Buzzard, K.; Van der Walt, A.; Karabudak, R.; VAN WIJMEERSCH, Bart; Csepany, T.; Spitaleri, D.; Vucic, S.; Koch-Henriksen, N.; Sellebjerg, F.; Soerensen , P. S.; Christensen, C. C. Hilt; Rasmussen, P., V; Jensen, M. B.; Frederiksen, J. L.; Bramow, S.; Mathiesen, H. K.; Schreiber, K., I; Butzkueven, H.; Magyari, M.; Kalincik, T.; Leray, E. | Journal Contribution | A1 |
| 18 | 2022 | Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide | VAN WIJMEERSCH, Bart; Hartung, Hans-Peter; Vermersch, Patrick; Pugliatti, Maura; Pozzilli, Carlo; Grigoriadis, Nikolaos; Alkhawajah, Mona; Airas, Laura; Linker, Ralf; Oreja-Guevara, Celia | Journal Contribution | A1 |
| 19 | 2022 | Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in | Pugliatti, M; Hartung, HP; Oreja-Guevara, C; Pozzilli, C; Airas, L; Alkhawajah, M; Grigoriadis, N; Magyari, M; VAN WIJMEERSCH, Bart; Zakaria, M; Linker, R; Chan, A; Vermersch, P; Berger, T | Journal Contribution | A1 |
| 20 | 2022 | Confirmed disability progression as a marker of permanent disability in multiple sclerosis | Sharmin, Sifat; Bovis, Francesca; Malpas, Charles; Horakova, Dana; Havrdova, Eva Kubala; Izquierdo, Guillermo; Eichau, Sara; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Onofrj, Marco; Lugaresi, Alessandra; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Terzi, Murat; Gerlach, Oliver; Alroughani, Raed; Boz, Cavit; Shaygannejad, Vahid; van Pesch, Vincent; Cartechini, Elisabetta; Kappos, Ludwig; Lechner-Scott, Jeannette; Bergamaschi, Roberto; Turkoglu, Recai; Solaro, Claudio; Iuliano, Gerardo; Granella, Franco; VAN WIJMEERSCH, Bart; Spitaleri, Daniele; Slee, Mark; McCombe, Pamela; Prevost, Julie; Ampapa, Radek; Ozakbas, Serkan; Sanchez-Menoyo, Jose Luis; Soysal, Aysun; Vucic, Steve; Petersen, Thor; de Gans, Koen; Butler, Ernest; Hodgkinson, Suzanne; Sidhom, Youssef; Gouider, Riadh; Cristiano, Edgardo; Castillo-Trivino, Tamara; Saladino, Maria Laura; Barnett, Michael; Moore, Fraser; Rozsa, Csilla; Yamout, Bassem; Skibina, Olga; van der Walt, Anneke; Buzzard, Katherine; Gray, Orla; Hughes, Stella; Sempere, Angel Perez; Singhal, Bhim; Fragoso, Yara; Shaw, Cameron; Kermode, Allan; Taylor, Bruce; Simo, Magdolna; Shuey, Neil; Al-Harbi, Talal; Macdonell, Richard; Dominguez, Jose Andres; Csepany, Tunde; Sirbu, Carmen Adella; Sormani, Maria Pia; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 21 | 2022 | Efficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation | Zhu, C.; Kalincik, T.; Horakova, D.; Zhen, Z.; Buzzard, K.; Skibina, O.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Kuhle, J.; Patti, F.; Grand'Maison, F.; Hodgkinson, S.; Grammond, P.; Lechner-Scott, J.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Macdonell, R.; Weinstock-Guttman, B.; Ozakbas, S.; Slee, M.; Sa, M. Jose; Van Pesch, V.; Barnett, M.; VAN WIJMEERSCH, Bart; Gerlach, O.; Prevost, J.; Terzi, M.; Boz, C.; Laureys, G.; Van Hijfte, L.; Kermode, A.; Garber, J.; Yamout, B.; Khoury, S. J.; Jokubaitis, V.; Monif, M.; Merlo, D.; Van der Walt, A.; Butzkueven, H. | Journal Contribution | M |
| 22 | 2022 | Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS | Kalincik, T.; Sharman, S.; Roos, I.; Freedman, M.; Atkins, H.; Burman, J.; Massey, J.; Sutton, I.; Withers, B.; Macdonell, R.; Grigg, A.; Torkildsen, O.; Bo, L.; Lehmann, A.; Horakova, D.; Havrdova, E.; Krasulova, E.; Trneny, M.; Kozak, T.; van der Walt, A.; Butzkueven, H.; McCombe, P.; VAN WIJMEERSCH, Bart; Buzzard, K.; Skibina, O.; Lechner-Scott, J.; Willekens, B.; Barnett, M.; Cartechini, E.; Ozakbas, S.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Boz, C.; Kuhle, J.; Patti, F.; Terzi, M.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Onofrj, M.; Lugaresi, A.; Khoury, S.; Soysal, A.; Slee, M.; Prevost, J.; Turkoglu, R.; Sharrack, B.; Snowden, J. | Journal Contribution | M |
| 23 | 2022 | Cognitive improvements accompanied with WPAI improvements in OCR-treated patients with RRMS: 96-week CASTING data | Vermersch, P.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T.; Benedict, R. | Journal Contribution | M |
| 24 | 2022 | Safety of Alemtuzumab in Patients with Multiple Sclerosis: Interim Results of a Post-Authorization Safety Study (PASS) | Montalban, X.; VAN WIJMEERSCH, Bart; Gobbi, C.; Robertson, N.; Klotz, L.; Achiron, A.; Lee, A.; Eichau, S.; Vecsei, L.; Benzerdjeb, H.; Rodrigues, A.; Jurgensen, S.; Chirieac, M.; Comi, G. | Journal Contribution | M |
| 25 | 2022 | Efficacy and safety of ocrelizumab is maintained in patients with RRMS with suboptimal response to prior disease-modifying therapies: 4-year NEDA data from CASTING-LIBERTO | Oreja-Guevara, C.; Benedict, R. H.; Comi, G.; Cutter, G.; Kister, I.; Siva, A.; Wiendl, H.; VAN WIJMEERSCH, Bart; Wuerfel, J.; El Azzouzi, B.; Buffels, R.; Dirks, P.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 26 | 2022 | Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis | Daruwalla, C.; Shaygannejad, V.; Ozakbas, S.; Havrdova, E. K.; Alroughani, R.; Patti, F.; Onofrj, M.; Eichau, S.; Girard, M.; Grand'Maison, F.; Yamout, B.; Sajedi, S. A.; Amato, M. P.; Altintas, A.; Skibina, O.; Grammond, P.; Butzkueven, H.; Maimone, D.; Lechner-Scott, J.; Soysal, A.; John, N.; Gerlach, O.; Iuliano, G.; Foschi, M.; Van Pesch, V.; Cartechini, E.; Kuhle, J.; Sa, M. J.; Kermode, A.; Gouider, R.; Hodgkinson, S.; McCombe, P.; Sanchez-Menoyo, J. L.; Singhal, B.; Blanco, Y.; Hughes, S.; McGuigan, C.; Taylor, B.; Habek, M.; Al-Asmi, A.; Mihaela, S.; Castillo Trivino, T.; Al-Harbi, T.; Rojas, J. I.; Gray, O.; Khurana, D.; VAN WIJMEERSCH, Bart; Coles, A.; Kalincik, T.; Brown, J. W. L. | Journal Contribution | M |
| 27 | 2022 | Comparative effectiveness of autologous haematopoietic stem cell transplantation with immune reconstitution therapies in relapsing-remitting MS | Kalincik, T.; Sharmin , S.; Roos, I.; Freedman, M. S.; Atkins, H.; Burman, J.; Massey, J.; Sutton, I.; Withers, B.; Macdonell, R.; Grigg, A.; Torkildsen, O.; Bo, L.; Lehmann, A. K.; Horakova, D.; Havrdova, E. K.; Krasulova, E.; Trneny, M.; Kozak, T.; van der Walt, A.; Butzkueven, H.; VAN WIJMEERSCH, Bart; McCombe, P.; Buzzard, K.; Skibina, O.; Lechner-Scott, J.; Willekens, B.; Barnett, M.; Cartechini, E.; Izquierdo, G.; Eichau, S.; Patti, F.; Hodgkinson, S.; Prevost, J.; Onofrj, M.; Lugaresi, A.; Alroughani, R.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Grammond, P.; Grand'Maison, F.; Laureys, G.; Van Hijfte, L.; Maimone, D.; Sharrack, B.; Snowden, J. | Journal Contribution | M |
| 28 | 2022 | Cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 29 | 2022 | Employment and cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data | Wiendl, H.; Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 30 | 2022 | Walking fatigability manifests globally in several gait domains in people with multiple sclerosis during a prolonged walking | BALISTIERI SANTINELLI, Felipe; RAMARI FERREIRA, Cintia; GYSEMBERG, Griet; VAN WIJMEERSCH, Bart; Kos, D.; MEYNS, Pieter; FEYS, Peter | Journal Contribution | M |
| 31 | 2022 | Employment and Cognitive Improvements in Ocrelizumab-Treated Patients with Relapsing-Remitting Multiple Sclerosis: 96-Week CASTING Study Data | Wiendl, H.; Benedict, R.H.B.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T.; Vermersch, P. | Conference Material | C2 |
| 32 | 2022 | Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180] | DE BROUWER, Edward; BECKER, Thijs; Moreau, Yves; Havrdova, Eva Kubala; Trojano, Maria; Eichau, Sara; Ozakbas, Serkan; Onofrj, Marco; Grammond, Pierre; Kuhle, Jens; Kappos, Ludwig; Sola, Patrizia; Cartechini, Elisabetta; Lechner-Scott, Jeannette; Alroughani, Raed; Gerlach, Oliver; Kalincik, Tomas; Granella, Franco; Grand'Maison, Francois; VAN WIJMEERSCH, Bart; Bergamaschi, Roberto; Sá, Maria José; Soysal, Aysun; Sanchez-Menoyo, Jose Luis; Solaro, Claudio; Boz, Cavit; Iuliano, Gerardo; Buzzard, Katherine; Aguera-Morales, Eduardo; Terzi, Murat; Trivio, Tamara Castillo; Spitaleri, Daniele; Van Pesch, Vincent; Shaygannejad, Vahid; Moore, Fraser; Oreja-Guevara, Celia; Maimone, Davide; Gouider, Riadh; Csepany, Tunde; Ramo-Tello, Cristina; PEETERS, Liesbet | Journal Contribution | A1 |
| 33 | 2022 | Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial | Vermersch, Patrick; Oreja-Guevara, Celia; Siva, Aksel; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Wuerfel, Jens; Buffels, Regine; Kadner, Karen; Kuenzel, Thomas; Comi, Giancarlo | Journal Contribution | A1 |
| 34 | 2022 | Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset | YPERMAN, Jan; POPESCU, Veronica; VAN WIJMEERSCH, Bart; BECKER, Thijs; PEETERS, Liesbet | Journal Contribution | A1 |
| 35 | 2022 | A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis | AERTS, Sofie; KHAN, Hamza; SEVERIJNS, Deborah; POPESCU, Veronica; PEETERS, Liesbet; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 36 | 2022 | A multi-stakeholder survey on multiple sclerosis multidisciplinary care: The situation in Belgium and lessons for the global community | Van Hijfte, L.; Cambron, M.; Capron, B.; Dachy, B.; Decoo, D.; Dive, D.; Dubois, B.; El Sankari, S.; London, F.; Perrotta, G.; POPESCU, Veronica; Van Pesch, V.; VAN WIJMEERSCH, Bart; Willekens, B.; Laureys, G. | Journal Contribution | M |
| 37 | 2022 | Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells | BAETEN, Paulien; HAMAD, Ibrahim; HOEKS, Cindy; Hiltensperger, Michael; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Aly, Lilian; SOMERS, Veerle; Korn, Thomas; KLEINEWIETFELD, Markus; HELLINGS, Niels; BROUX, Bieke | Preprint | O |
| 38 | 2021 | Multicentric motor evoked potentials in multiple sclerosis: a retrospective pilot study | DEKEYSER, Catherine; YPERMAN, Jan; KHAN, Hamza; VAN WIJMEERSCH, Bart; Verhoeven, K.; Cambron, M.; BECKER, Thijs; Laureys, G.; PEETERS, Liesbet | Journal Contribution | M |
| 39 | 2021 | Outcomes in Alemtuzumab-Treated Patients With Thyroid Adverse Events: 6-Year Pooled CARE-MS Data | Dayan, Colin; Lecumberri, Beatriz; Muller, Ilaria; Ganesananthan, Sashiananthan; Hunter, Samuel F.; Selmaj, Krzysztof W.; Hartung, Hans-Peter; Havrdova, Eva K.; LaGanke, Christopher C.; Ziemssen, Tjalf; VAN WIJMEERSCH, Bart; Meuth, Sven G.; Margolin, David H.; Afsar, Salman; Daizadeh, Nadia; Poole, Elizabeth M.; Baker, Darren P.; Senior, Peter A. | Journal Contribution | M |
| 40 | 2021 | Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results | VAN WIJMEERSCH, Bart; Comi, G.; Oreja-Guevara, C.; Wiendl, H.; Wuerfel, J.; Buffels, R.; Dirks, P.; Kuenzel, T.; Kadner, K.; Vermersch, P. | Journal Contribution | M |
| 41 | 2021 | Differential effects and discriminative validity of motor and cognitive tasks varying in difficulty on cognitive–motor interference in persons with multiple sclerosis | VELDKAMP, Renee; Kalron, Alon; BAERT, Ilse; Hamalainen, Paivi; Tacchino, Andrea; D'HOOGE, Mieke; GIFFROY, Xavier; VAN GEEL, Fanny; RAATS, Joke; CONINX, Karin; VAN WIJMEERSCH, Bart; FEYS, Peter | Journal Contribution | A1 |
| 42 | 2021 | Clinical manifestation and perceived symptoms of walking-related performance fatigability in persons with multiple sclerosis | VAN GEEL, Fanny; Bielen, H; THEUNISSEN, Kyra; MOUMDJIAN, Lousin; Van Nieuwenhoven, J; VAN WIJMEERSCH, Bart; MEESEN, Raf; Ramari, C; FEYS, Peter | Journal Contribution | A1 |
| 43 | 2021 | The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies | Andersen, Johanna B.; Lefort, Mathilde; Koch-Henriksen, Nils; Sellebjerg, Finn; Sorensen, Per Soelberg; Christensen, Claudia C. Hilt; Rasmussen, Peter, V; Jensen, Michael B.; Frederiksen, Jette L.; Bramow, Stephan; Mathiesen, Henrik K.; Schreiber, Karen, I; Horakova, Dana; Havrdova, Eva K.; Alroughani, Raed; Izquierdo, Guillermo; Eichau, Sara; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Terzi, Murat; Grammond, Pierre; Maison, Francois Grand; Yamout, Bassem; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Trojano, Maria; McCombe, Pamela; Slee, Mark; Lechner-Scott, Jeannette; Turkoglu, Recai; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Shaygannejad, Vahid; Prevost, Julie; Skibina, Olga; Solaro, Claudio; Karabudak, Rana; VAN WIJMEERSCH, Bart; Csepany, Tunde; Spitaleri, Daniele; Vucic, Steve; Casey, Romain; Debouverie, Marc; Edan, Gilles; Ciron, Jonathan; Ruet, Aurelie; Seze, Jerome D.; Maillart, Elisabeth; Zephir, Helene; Labauge, Pierre; Defer, Gilles; Lebrun, Christine; Moreau, Thibault; Clavelou, Pierre; Pelletier, Jean; Stankoff, Bruno; Gout, Olivier; Thouvenot, Eric; Heinzlef, Olivier; Al-Khedr, Abdullatif; Bourre, Bertrand; Casez, Olivier; Cabre, Philippe; Montcuquet, Alexis; Wahab, Abir; Camdessanche, Jean-Philippe; Marousset, Aude; Patry, Ivania; Hankiewicz, Karolina; Pottier, Corinne; Maubeuge, Nicolas; Labeyrie, Celine; Nifle, Chantal; Leray, Emmanuelle; Laplaud, David A.; Butzkueven, Helmut; Kalincik, Tomas; Vukusic, Sandra; Magyari, Melinda; Berger, Eric; Sharmin, Sifat | Journal Contribution | A1 |
| 44 | 2021 | Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression | DE BROUWER, Edward; BECKER, Thijs; Moreau, Yves; Havrdova, Eva; Trojano, Maria; Eichau, Sara; Ozakbas, Serkan; Onofrj, Marco; Grammond, Pierre; Kuhle, Jens; Kappos, Ludwig; Sola, Patrizia; Cartechini, Elisabetta; Lechner-Scott, Jeannette; Alroughani, Raed; Gerlach, Oliver; Kalincik, Tomas; Granella, Franco; Grand'maison, Francois; Bergamaschi, Roberto; José Sá, Maria; VAN WIJMEERSCH, Bart; Soysal, Aysun; Sanchez-Menoyo, Jose; Solaro, Claudio; Boz, Cavit; Iuliano, Gerardo; Buzzard, Katherine; Aguera-Morales, Eduardo; Terzi, Murat; Trivio, Tamara; Spitaleri, Daniele; Van Pesch, Vincent; Shaygannejad, Vahid; Moore, Fraser; Oreja-Guevara, Celia; Maimone, Davide; Gouider, Riadh; Csepany, Tunde; Ramo-Tello, Cristina; PEETERS, Liesbet | Journal Contribution | A1 |
| 45 | 2021 | Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts | Sharmin, Sifat; Lefort, Mathilde; Andersen, Johanna Balslev; Leray, Emmanuelle; Horakova, Dana; Havrdova, Eva Kubala; Alroughani, Raed; Izquierdo, Guillermo; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; Terzi, Murat; Grammond, Pierre; Grand'Maison, Francois; Yamout, Bassem; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Trojano, Maria; McCombe, Pamela; Slee, Mark; Lechner-Scott, Jeannette; Turkoglu, Recai; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Prevost, Julie; Maimone, Davide; Skibina, Olga; Buzzard, Katherine; Van der Walt, Anneke; VAN WIJMEERSCH, Bart; Csepany, Tunde; Spitaleri, Daniele; Vucic, Steve; Casey, Romain; Debouverie, Marc; Edan, Gilles; Ciron, Jonathan; Ruet, Aurelie; De Seze, Jerome; Maillart, Elisabeth; Zephir, Helene; Labauge, Pierre; Defer, Gilles; Lebrun-Frenay, Christine; Moreau, Thibault; Berger, Eric; Clavelou, Pierre; Pelletier, Jean; Stankoff, Bruno; Gout, Olivier; Thouvenot, Eric; Heinzlef, Olivier; Al-Khedr, Abullatif; Bourre, Bertrand; Casez, Olivier; Cabre, Philippe; Montcuquet, Alexis; Wahab, Abir; Camdessanche, Jean-Philippe; Maurousset, Aude; Patry, Ivania; Hankiewicz, Karolina; Pottier, Corinne; Maubeuge, Nicolas; Labeyrie, Celine; Nifle, Chantal; Laplaud, David; Koch-Henriksen, Niels; Sellebjerg, Finn Thorup; Soerensen, Per Soelberg; Pfleger, Claudia Christina; Rasmussen, Peter Vestergaard; Jensen, Michael Broksgaard; Frederiksen, Jette Lautrup; Bramow, Stephan; Mathiesen, Henrik Kahr; Schreiber, Karen Ingrid; Magyari, Melinda; Vukusic, Sandra; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 46 | 2021 | IgD-CD27-double negative (DN) B cells of multiple sclerosis patients are mature memory cells that can migrate towards pro-inflammatory chemokines | BECKERS, Lien; MONTES DIAZ, Gwendoline; Maria Villar, Luisa; VAN WIJMEERSCH, Bart; POPESCU, Veronica; SOMERS, Veerle; FRAUSSEN, Judith | Journal Contribution | M |
| 47 | 2021 | Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score | Kunchok, Amy; Lechner-Scott, Jeannette; Granella, Franco; Trojano, Maria; Alroughani, Raed; Sola, Patrizia; Ferraro, Diana; Lugaresi, Alessandra; Onofrj, Marco; Ozakbas, Serkan; Izquierdo, Guillermo; Grammond, Pierre; Luis Sanchez-Menoyo, Jose; VAN WIJMEERSCH, Bart; Boz, Cavit; Pucci, Eugenio; McCombe, Pamela; Grand'Maison, Francois; Spitaleri, Daniele; Vucic, Steve; Hupperts, Raymond; Jokubaitis, Vilija; Sormani, Maria Pia; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 48 | 2021 | The Multiple Sclerosis Data Alliance Catalogue; Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources | GEYS, Lotte; PARCIAK, Tina; PIRMANI, Ashkan; McBurney, Robert; Schmidt, Hollie; Malbaša, Tanja; Ziemssen, Tjalf; Bergmann, Arnfin; Rojas, Juan I.; Cristiano, Edgardo; García-Merino, Juan Antonio; Fernández, Óscar; Kuhle, Jens; Gobbi, Claudio; Delmas, Amber; Simpson-Yap, Steve; Nag, Nupur; Yamout, Bassem; Steinemann, Nina; Seeldrayers, Pierrette; Dubois, Bénédicte; van der Mei, Ingrid; Stahmann, Alexander; Drulovic, Jelena; Pekmezovic, Tatjana; Brola, Waldemar; Tintore, Mar; Kalkers, Nynke; Ivanov, Rumen; Zakaria, Magd; Naseer, Maged Abdel; Van Hecke, Wim; Grigoriadis, Nikolaos; Boziki, Marina; Carra, Adriana; Pawlak, Mikolaj A.; Dobson, Ruth; Hellwig, Kerstin; Gallagher, Arlene; Leocani, Letizia; Dalla Costa, Gloria; de Carvalho Sousa, Nise Alessandra; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | A1 |
| 49 | 2021 | Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data research | PEETERS, Liesbet; PARCIAK, Tina; Kalra, Dipak; Moreau, Yves; Kasilingam, Elisabeth; Galen, Pieter van; Thalheim, Christoph; Uitdehaag, Bernard; Vermersch, Patrick; HELLINGS, Niels; STINISSEN, Piet; VAN WIJMEERSCH, Bart; Ardeshirdavani, Amin; PIRMANI, Ashkan; Brouwer, Edward De; Bauer, Christian Robert; Krefting, Dagmar; Ribbe, Stephanie; Middleton, Rod; Stahmann, Alexander; Comi, Giancarlo | Journal Contribution | A1 |
| 50 | 2021 | Determinants of therapeutic lag in multiple sclerosis | Roos, I; Leray, E; Frascoli, F; Casey, R; Brown, JWL; Horakova, D; Havrdova, EK; Debouverie, M; Trojano, M; Patti, F; Izquierdo, G; Eichau, S; Edan, G; Prat, A; Girard, M; Duquette, P; Onofrj, M; Lugaresi, A; Grammond, P; Ciron, J; Ruet, A; Ozakbas, S; De Seze, J; Louapre, C; Zephir, H; Sa, MJ; Sola, P; Ferraro, D; Labauge, P; Defer, G; Bergamaschi, R; Lebrun-Frenay, C; Boz, C; Cartechini, E; Moreau, T; Laplaud, D; Lechner-Scott, J; Grand'Maison, F; Gerlach, O; Terzi, M; Granella, F; Alroughani, R; Iuliano, G; Van Pesch, V; VAN WIJMEERSCH, Bart; La Spitaleri, D; Soysal, A; Berger, E.; Prevost, J; Aguera-Morales, E; McCombe, P; Trivino, TC; Clavelou, P; Pelletier, J; Turkoglu, R; Stankoff, B; Gout, O; Thouvenot, E; Heinzlef, O; Sidhom, Y; Gouider, R; Csepany, T; Bourre, B; Al Khedr, A; Casez, O; Cabre, P; Montcuquet, A; Wahab, A; Camdessanche, JP; Maurousset, A; Patry, I; Hankiewicz, K; Pottier, C; Maubeuge, N; Labeyrie, C; Nifle, C; Coles, A; Malpas, CB; Vukusic, S; Butzkueven, H; Kalincik, T | Journal Contribution | A1 |
| 51 | 2021 | Application of step and beat alignment approaches and its effect on gait in progressive multiple sclerosis with severe cerebellar ataxia: A proof of concept case study | MOUMDJIAN, Lousin; Moens, Bart; VAN WIJMEERSCH, Bart; Leman, Marc; FEYS, Peter | Journal Contribution | A1 |
| 52 | 2021 | Characterisation of the innate and adaptive immune system after ocrelizumab treatment in multiple sclerosis | BECKERS, Lien; BAETEN, Paulien; SWINNEN, Dries; HAMAD, Ibrahim; Tavernier, S.; VAN WIJMEERSCH, Bart; POPESCU, Veronica; KLEINEWIETFELD, Markus; BROUX, Bieke; FRAUSSEN, Judith; SOMERS, Veerle | Journal Contribution | M |
| 53 | 2020 | Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study) | Hartung, H-P; Comi, G.; Arnold, D. L.; Boyko, A. N.; Havrdova, E. K.; Inshasi, J. S.; McCombe, P.; Nakamura, K.; Oreja-Guevara, C.; Pelletier, D.; Pozzilli, C.; Selmaj, K. W.; Scott, T. F.; Chung, L.; Daizadeh, N.; Afsar, S.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 54 | 2020 | Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results) | Vermersch, P.; Eralinna, J.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Wei, W.; Comi, G. | Journal Contribution | M |
| 55 | 2020 | One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study) | VAN WIJMEERSCH, Bart; Harrower, T.; Hobart, J.; Kizlaitiene, R.; Marfia, G. A.; Patti, F.; Pearson, O. R.; Van Pesch, V.; Vanderdonckt, P.; Vecsei, L.; Shor, S.; Achiron, A. | Journal Contribution | M |
| 56 | 2020 | Alemtuzumab Outcomes Over 9 Years in RRMS Patients With Highly Active Disease From CARE-MS I and II (TOPAZ) | Ziemssen, T.; Bass, A. D.; Berkovich, R.; Eichau, S.; Hobart, J.; Hunter, S. F.; Limmroth, V.; Pelletier, D.; Pozzilli, C.; Schippling, S.; Singer, B. A.; Sousa, L.; Traboulsee, A.; Uittlehaag, B. M. J.; VAN WIJMEERSCH, Bart; Poole, E. M.; Choudhry, Z.; Geertsen, S.; Daizadeh, N.; Comi, G. | Journal Contribution | M |
| 57 | 2020 | Disability accrual in primary-progressive & secondary-progressive multiple sclerosis | Harding-Forrester, S.; Roos, I.; Sharmin, S; Diouf, I.; Malpas, C.; Nguyen, A. -L.; Moradi, N.; Horakova, D.; Havrdova, E. Kubala; Patti, F.; Izquierdo, G.; Eichau, S.; Prat, A.; Girard, M.; Duquette, P.; Onofrj, M.; Lugaresi, A.; Grand'Maison, F.; Weinstock-Guttman, B.; Amato, M. P.; Grammond, P.; Gerlach, O.; Ozakbas, S.; Sola, P.; Ferraro, D.; Butzkueven, H.; Lechner-Scott, J.; Boz, C.; Alroughani, R.; Van Pesch, V.; Cartechini, E.; Terzi, M.; Maimone, D.; Ramo-Tello, C.; Spitaleri, D.; Kappos, L.; Yamout, B.; Sa, M.; Slee, M.; Blanco, Y.; Bergamaschi, R.; Butler, E.; Iuliano, G.; Granella, F.; Sidhom, Y.; Gouider, R.; Ampapa, R.; VAN WIJMEERSCH, Bart; Karabudak, R.; Prevost, J.; Sanchez-Menoyo, J. L.; Verheul, F.; Mccombe, P.; Castillo-Trivino, T.; Macdonell, R.; Altintas, A.; Laureys, G.; Van Hijfte, L.; Van der Walt, A.; Vucic, S.; Turkoglu, R.; Barnett, M.; Cristiano, E.; Zakaria, M.; Shaygannejad, V.; Hodgkinson, S.; Soysal, A.; Kalincik, T. | Journal Contribution | M |
| 58 | 2020 | Ocrelizumab phase iiib efficacy from casting: 2-year neda (mri re-baselined) subgroup rates in rrms patients with a suboptimal response to prior dmts | Wiendl, H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wuerfel, J.; Buffels, R.; Kadner, K.; Kuenzel, T.; Vermersch, P. | Journal Contribution | M |
| 59 | 2020 | Delay from treatment start to full effect of immunotherapies for multiple sclerosis | Roos, Izanne; Leray, Emmanuelle; Frascoli, Federico; Casey, Romain; Brown, J. William L.; Horakova, Dana; Havrdova, Eva K.; Trojano, Maria; Patti, Francesco; Izquierdo, Guillermo; Eichau, Sara; Onofrj, Marco; Lugaresi, Alessandra; Prat, Alexandre; Girard, Marc; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Ozakbas, Serkan; Bergamaschi, Roberto; Sa, Maria Jose; Cartechini, Elisabetta; Boz, Cavit; Granella, Franco; Hupperts, Raymond; Terzi, Murat; Lechner-Scott, Jeannette; Spitaleri, Daniele; Van Pesch, Vincent; Soysal, Aysun; Olascoaga, Javier; Prevost, Julie; Aguera-Morales, Eduardo; Slee, Mark; Csepany, Tunde; Turkoglu, Recai; Sidhom, Youssef; Gouider, Riadh; VAN WIJMEERSCH, Bart; McCombe, Pamela; Macdonell, Richard; Coles, Alasdair; Malpas, Charles B.; Butzkueven, Helmut; Vukusic, Sandra; Kalincik, Tomas | Journal Contribution | A1 |
| 60 | 2020 | CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis | BOGIE, Jeroen; GRAJCHEN, Elien; WOUTERS, Elien; BROUX, Bieke; STINISSEN, Piet; VAN WIJMEERSCH, Bart; HENDRIKS, Jerome | Journal Contribution | A1 |
| 61 | 2020 | The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective | Alroughani, Raed; VAN WIJMEERSCH, Bart; Al Khaboori, Jabber; Alsharoqi, Isa Ahmed; Ahmed, Samar F.; Hassan, Ali; Inshasi, Jihad; Krieger, Derk W.; Shakra, Mustafa; Shatila, Ahmed Osman; Szolics, Miklos; Khallaf, Mohamed; Ezzat, Aly | Journal Contribution | A1 |
| 62 | 2020 | Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management | Cuker, Adam; Bass, Ann D.; Nadj, Congor; Agius, Mark A.; Steingo, Brian; Selmaj, Krzysztof W.; Thoits, Timothy; Guerreiro, Alexandre; VAN WIJMEERSCH, Bart; Ziemssen, Tjalf; Meuth, Sven G.; LaGanke, Christopher C.; Thangavelu, Karthinathan; Rodriguez, Claudio E.; Baker, Darren P.; Margolin, David H.; Jannsens, Ann | Journal Contribution | A1 |
| 63 | 2020 | Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab | Wiendl, Heinz; Carraro, Matthew; Comi, Giancarlo; Izquierdo, Guillermo; Kim, Ho Jin; Sharrack, Basil; Tornatore, Carlo; Daizadeh, Nadia; Chung, Luke; Jacobs, Alan K.; Hogan, Richard J.; Wychowski, Linda V.; VAN WIJMEERSCH, Bart | Journal Contribution | A1 |
| 64 | 2020 | Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study | Ziemssen, Tjalf; Bass, Ann D.; Berkovich, Regina; Comi, Giancarlo; Eichau, Sara; Hobart, Jeremy; Hunter, Samuel F.; LaGanke, Christopher; Limmroth, Volker; Pelletier, Daniel; Pozzilli, Carlo; Schippling, Sven; Sousa, Livia; Traboulsee, Anthony; Uitdehaag, Bernard M. J.; VAN WIJMEERSCH, Bart; Choudhry, Zia; Daizadeh, Nadia; Singer, Barry A. | Journal Contribution | A1 |
| 65 | 2020 | Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies | VAN WIJMEERSCH, Bart; Singer, Barry A.; Boster, Aaron; Broadley, Simon; Fernandez, Oscar; Freedman, Mark S.; Izquierdo, Guillermo; Lycke, Jan; Pozzilli, Carlo; Sharrack, Basil; Steingo, Brian; Wiendl, Heinz; Wray, Sibyl; Ziemssen, Tjalf; Chung, Luke; Margolin, David H.; Thangavelu, Karthinathan; Vermersch, Patrick | Journal Contribution | A1 |
| 66 | 2020 | Risk of secondary progressive multiple sclerosis: A longitudinal study | Fambiatos, Adam; Jokubaitis, Vilija; Horakova, Dana; Havrdova, Eva Kubala; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Diana; Alroughani, Raed; Terzi, Murat; Hupperts, Raymond; Boz, Cavit; Lechner-Scott, Jeannette; Pucci, Eugenio; Bergamaschi, Roberto; Van Pesch, Vincent; Ozakbas, Serkan; Granella, Franco; Turkoglu, Recai; Iuliano, Gerardo; Spitaleri, Daniele; McCombe, Pamela; Solaro, Claudio; Slee, Mark; Ampapa, Radek; Soysal, Aysun; Petersen, Thor; Sanchez-Menoyo, Jose Luis; Verheul, Freek; Prevost, Julie; Sidhom, Youssef; VAN WIJMEERSCH, Bart; Vucic, Steve; Cristiano, Edgardo; Saladino, Maria Laura; Deri, Norma; Barnett, Michael; Olascoaga, Javier; Moore, Fraser; Skibina, Olga; Gray, Orla; Fragoso, Yara; Yamout, Bassem; Shaw, Cameron; Singhal, Bhim; Shuey, Neil; Hodgkinson, Suzanne; Altintas, Ayse; Al-Harbi, Talal; Csepany, Tunde; Taylor, Bruce; Hughes, Jordana; Jun, Jae-Kwan; van der Walt, Anneke; Spelman, Tim; Butzkueven, Helmut; Kalincik, Tomas | Journal Contribution | A1 |
| 67 | 2020 | Deciphering the Morphology of Motor Evoked Potentials | YPERMAN, Jan; BECKER, Thijs; VALKENBORG, Dirk; HELLINGS, Niels; Cambron, M; Dive, D; Laureys, G.; POPESCU, Veronica; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | A1 |
| 68 | 2020 | Comparing 16 Different Dual–Tasking Paradigms in Individuals With Multiple Sclerosis and Healthy Controls: Working Memory Tasks Indicate Cognitive–Motor Interference | LEONE, Carmela; MOUMDJIAN, Lousin; Patti, Francesco; VANZEIR, Ellen; BAERT, Ilse; VELDKAMP, Renee; VAN WIJMEERSCH, Bart; FEYS, Peter | Journal Contribution | A1 |
| 69 | 2020 | Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis | YPERMAN, Jan; BECKER, Thijs; VALKENBORG, Dirk; POPESCU, Veronica; HELLINGS, Niels; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | A1 |
| 70 | 2019 | Improved Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in Alemtuzumab-Treated RRMS Patients: 8-Year Follow-up of CARE-MS I (TOPAZ Study) | Pelletier, Daniel; Arnold, Douglas L.; Boyko, Alexey N.; Comi, Giancarlo; Hartung, Hans-Peter; Havrdova, Eva Kubala; Inshasi, Jihad Said; McCombe, Pamela; Nakamura, Kunio; Oreja-Guevara, Celia; Pozzilli, Carlo; Selmaj, Krzysztof W.; Scott, Thomas F.; Chung, Luke; Daizadeh, Nadia; Afsar, Salman; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 71 | 2019 | No Association Between Lymphocyte Pharmacodynamics and Disability Following Alemtuzumab Treatment in patients With Relapsing-Remitting Multiple Sclerosis | Meuth, Sven G.; Brandes, David; Carraro, Matthew; Comi, Giancarlo; Mao-Draayer, Yang; Izquierdo, Guillermo; Kim, Ho Jin; Pardo, Gabriel; Sharrack, Basil; Tornatore, Carlo; VAN WIJMEERSCH, Bart; Ziemssen, Tjalf; Jacobs, Alan; Chung, Luke; Daizadeh, Nadia; Wiendl, Heinz | Journal Contribution | M |
| 72 | 2019 | Baseline characteristics of patients enrolled in LEMQoL, a study assessing health-related quality of life in RRMS patients treated with alemtuzumab in a real-world clinical setting | VAN WIJMEERSCH, Bart; Patti, F.; Hobart, J.; Kizlaitiene, R.; Vanderdonckt, P.; Shor, S.; Andreasen, A. K.; Uitdehaag, B. M. | Journal Contribution | M |
| 73 | 2019 | Neuromyelitis Optica in Flanders: an epidemiological study | Blomme, L.; MOONS, Lynn; Noels, S.; Laureys, G.; VAN WIJMEERSCH, Bart; Crols, R.; DE KLIPPEL, Nina; Van de Velde, K.; Willekens, B. | Journal Contribution | M |
| 74 | 2019 | Alemtuzumab improves clinical and MRI outcomes, including slowing of brain volume loss, in RRMS patients over 8 years: CARE-MS I follow-up (TOPAZ Study) | Comi, G.; Arnold, D. L.; Boyko, A. N.; Hartung, H. -P.; Havrdova, E. K.; Inshasi, J. S.; McCombe, P.; Nakamura, K.; Oreja-Guevara, C.; Pelletier, D.; Pozzilli, C.; Selmaj, K. W.; Scott, T. F.; Chung, L.; Daizadeh, N.; Afsar, S.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 75 | 2019 | Use of other disease-modifying therapies after or between alemtuzumab treatments: pooled results from the CAMMS223, and CARE-MS I and II studies over 8 years | Vermersch, P.; Baker, M.; Bass, A. D.; Berkovich, R.; Comi, G.; Eichau, S.; Graves, D.; Hunter, S. F.; Ionete, C.; Limmroth, V.; Meuth, S. G.; Naismith, R. T.; Sharrack, B.; Subei, A.; Daizadeh, N.; Choudhry, Z.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 76 | 2019 | Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study) | Montalban, X.; Barone, D.; Broadley, S.; Dive, D.; Hupperts, R. M.; Lycke, J.; Massacesi, L.; Naismith, R. T.; Nakamura, K.; Pandey, K.; Schippling, S.; Vermersch, P.; Wiendl, H.; Chung, L.; Daizadeh, N.; Afsar, S.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 77 | 2019 | Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study) | McCombe, P.; Comi, G.; Arnold, D. L.; Boyko, A. N.; Hartung, H-P; Havrdova, E. K.; Inshasi, J. S.; Nakamura, K.; Oreja-Guevara, C.; Pelletier, D.; Pozzilli, C.; Selmaj, K. W.; Scott, T. F.; Chung, L.; Daizadeh, N.; Afsar, S.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 78 | 2019 | Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies | VAN WIJMEERSCH, Bart; Buffels, R.; Clinch, S.; Kuhelj, R.; Wei, W.; Vermersch, P. | Journal Contribution | M |
| 79 | 2019 | Therapeutic lag in relapsing multiple sclerosis | ROOSEN, Inge; Frascoli, F.; Horakova, D.; Havrdova, E. K.; Trojano, M.; Izquierdo, G.; Eichau, S.; Patti, F.; Onofr, M.; Lugaresi, A.; Prat, A.; Girard, M.; Duquette, P.; Ozakbas, S.; Grammond, P.; Sola, P.; Ferraro, D.; Bergamaschi, R.; Boz, C.; Cartechini, E.; Sa, M. J.; Terzi, M.; Alroughani, R.; Grand'Maison, F.; Granella, F.; Iuliano, G.; Hupperts, R.; Lechner-Scott, J.; Spitaleri, D.; Van Pesch, V.; Soysal, A.; Prevost, J.; Aguera-Morales, E.; Olascoaga, J.; Turkoglu, R.; Sidhom, Y.; Gouider, R.; VAN WIJMEERSCH, Bart; Butzkueven, H.; Malpas, C.; Kalincik, T. | Journal Contribution | M |
| 80 | 2019 | Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial | Cambron, Melissa; Mostert, Jop; D'Hooghe, Marie; Nagels, Guy; Willkens, Barbara; Debruyne, Jan; Algoed, Luc; Verhagen, Winn; Hupperts, Raymond; Heersema, Dorothea; De Keyser, Jacques; De Groot, Liesbeth; Foselle, Erwin; Guillaume, Daniel; Merckx, Henri; Vanopdenbosch, Ludo; Vokaer, Mathieu; DE KLIPPEL, Nina; Nuytten, Dirk; Van Remoortel, Ann; Symons, Anoek; D'haeseleer, Miguel; Bissay, Veronique; Van Merhaegen-Wieleman, Annick; Van Lint, Michel; Michiels, Veronique; Haentjens, Patrick; VAN WIJMEERSCH, Bart; Tillemans, Bart; Van Hecke, Wim; Hengstman, Gerald | Journal Contribution | A1 |
| 81 | 2019 | Comparison of the effectiveness of rituximab versus alemtuzumab and natalizumab in active relapsing-remitting MS | Kalincik, T.; Malpas, C. B.; ROOSEN, Inge; Patti, F.; Butzkueven, H.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Onofrj, M.; Lugaresi, A.; Hupperts, R.; Lechner-Scott, J.; Sola, P.; Ferraro, D.; Grammond, P.; Csepany, T.; Grand'Maison, F.; Yamout, B.; Prat, A.; Girard, M.; Duquette, P.; VAN WIJMEERSCH, Bart; Granella, F.; Sa, M. J.; Bergamaschi, R.; Slee, M.; Boz, C.; Ozakbas, S.; Terzi, M.; Prevost, J.; Solaro, C.; Macdonell, R.; Cartechini, E.; Coles, A.; Havrdova, E. K.; Horakova, D. | Journal Contribution | M |
| 82 | 2019 | Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1-year interim results) | Vermersch, P.; Eralinna, J. -P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Buffels, R.; Kuhelj, R.; Wei, W.; Comi, G. | Journal Contribution | M |
| 83 | 2019 | Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression | DE BROUWER, Edward; PEETERS, Liesbet; BECKER, Thijs; Altintas, A.; Soysal, A.; VAN WIJMEERSCH, Bart; Boz, C.; Oreja-Guevara, C.; Gobbi, C.; Solaro, C.; Ramo, C.; Spitaleri, D. L.; Maimone, D.; Aguera-Morales, E.; Cartechini, E.; Butler, E.; Havrdova, E.; Patti, F.; Granella, F.; Grand'Maison, F.; Moore, F.; Verheul, F.; Luliano, G.; Butzkueven, H.; Lechner-Scott, J.; Kuhle, J.; Sanchez Menoyo, J. L.; Rojas, J. I.; Prevost, J.; Onofrj, M.; Rio, M. E.; Sa, M. J.; Saladino, M. L.; Slee, M.; Barnett, M.; Terzi, M.; Deri, N.; McCombe, P.; Sola, P.; Duquette, P.; Grammond, P.; Ampapa, R.; Alroughani, R.; Hupperts, R.; Turkoglu, R.; Gouider, R.; Fernandez Bolanos, R.; Bergamaschi, R.; Kalincik, T.; Moreau, Y. | Journal Contribution | M |
| 84 | 2019 | Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings | Barclay, Krista; Carruthers, Robert; Traboulsee, Anthony; Bass, Ann D.; LaGanke, Christopher; Bertolotto, Antonio; Boster, Aaron; Celius, Elisabeth G.; de Seze, Jerome; Dela Cruz, Dionisio; Habek, Mario; Lee, Jong-Mi; Limmroth, Volker; Meuth, Sven G.; Oreja-Guevara, Celia; Pagnotta, Patricia; Vos, Cindy; Ziemssen, Tjalf; Baker, Darren P.; VAN WIJMEERSCH, Bart | Journal Contribution | A1 |
| 85 | 2019 | Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis | Kalincik, Tomas; Havrdova, Eva Kubala; Horakova, Dana; Izquierdo, Guillermo; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Grammond, Pierre; Onofrj, Marco; Lugaresi, Alessandra; Ozakbas, Serkan; Kappos, Ludwig; Kuhle, Jens; Terzi, Murat; Lechner-Scott, Jeannette; Boz, Cavit; Grand'Maison, Francois; Prevost, Julie; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Trojano, Maria; Bergamaschi, Roberto; Pucci, Eugenio; Turkoglu, Recai; McCombe, Pamela A.; Van Pesch, Vincent; VAN WIJMEERSCH, Bart; Solaro, Claudio; Ramo-Tello, Cristina; Slee, Mark; Alroughani, Raed; Yamout, Bassem; Shaygannejad, Vahid; Spitaleri, Daniele; Luis Sanchez-Menoyo, Jose; Ampapa, Radek; Hodgkinson, Suzanne; Karabudak, Rana; Butler, Ernest; Vucic, Steve; Jokubaitis, Vilija; Spelman, Tim; Butzkueven, Helmut | Journal Contribution | A1 |
| 86 | 2019 | Predicting long-term sustained disability progression in multiple sclerosis | SHARMIN, Sohely; Malpas, C.; Horakova, D.; Havrdova, E. K.; Izquierdo, G.; Eichau, S.; Trojano, M.; Prat, A.; Girard, M.; Duquette, P.; Onofrj, M.; Lugaresi, A.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Terzi, M.; Hupperts, R.; Alroughani, R.; Boz, C.; Shaygannejad, V.; Van Pesch, V.; Cartechini, E.; Kappos, L.; Lechner-Scott, J.; Bergamaschi, R.; Turkoglu, R.; Solaro, C.; Ramo-Tello, C.; Iuliano, G.; Granella, F.; VAN WIJMEERSCH, Bart; Spitaleri, D.; Bolanos, R. F.; Slee, M.; McCombe, P.; Prevost, J.; Ampapa, R.; Ozakbas, S.; Sanchez-Menoyo, J. L.; Soysal, A.; Vucic, S.; Petersen, T.; Verheul, F.; Butler, E.; Hodgkinson, S.; Sidhom, Y.; Gouider, R.; Butzkueven, H.; Kalincik, T. | Journal Contribution | M |
| 87 | 2019 | Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis | SHARMIN, Sohely; Lefort, M.; Andersen, J.; Horakova, D.; Havrdova, E. K.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Ozakbas, S.; Butzkueven, H.; Patti, F.; Onofrj, M.; Lugaresi, A.; Terzi, M.; Grammond, P.; Grand'Maison, F.; Yamout, B.; Prat, A.; Girard, M.; Duquette, P.; Boz, C.; Trojano, M.; McCombe, P.; Slee, M.; Lechner-Scott, J.; Turkoglu, R.; Sola, P.; Ferraro, D.; Granella, F.; Shaygannejad, V.; Prevost, J.; Skibina, O.; Solaro, C.; Karabudak, R.; VAN WIJMEERSCH, Bart; Csepany, T.; Spitaleri, D.; Vucic, S.; Leray, E.; Sorensen, P. S.; Sellebjerg, F.; Magyari, M.; Vukusic, S.; Kalincik, T. | Journal Contribution | M |
| 88 | 2019 | Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD-CD27- Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients | FRAUSSEN, Judith; Marquez, Susanna; Takata, Kazushiro; BECKERS, Lien; MONTES DIAZ, Gwendoline; Zografou, Chrysoula; VAN WIJMEERSCH, Bart; Villar, Luisa M.; O'Connor, Kevin C.; Kleinstein, Steven H.; SOMERS, Veerle | Journal Contribution | A1 |
| 89 | 2019 | IgD(-)CD27(-) double negative B cells of multiple sclerosis patients have a pro-inflammatory migratory phenotype and function | BECKERS, Lien; Diaz, G. Montes; Villar, L. M.; VAN WIJMEERSCH, Bart; SOMERS, Veerle; FRAUSSEN, Judith | Journal Contribution | M |
| 90 | 2019 | Effects of an individual 12-week community-located "start-to-run" program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis. | Lousin Moumdjian; FEYS, Peter; Paul van Asch; Veronica Popescu; Bart Van Wijmeersch; Bert Opt' Eijnde; Inez Wens; Florian Van Haleweyck; Peter Feys; MOUMDJIAN, Lousin; VAN HALEWYCK, Florian; WENS, Inez; OP 'T EIJNDE, Bert; VAN WIJMEERSCH, Bart; POPESCU, Veronica; VAN ASCH, Paul | Journal Contribution | A1 |
| 91 | 2019 | A pilot study of the effects of running training on visuospatial memory in MS: A stronger functional embedding of the hippocampus in the default-mode network? | Huiskamp, Marijn; MOUMDJIAN, Lousin; VAN ASCH, Paul; POPESCU, Veronica; Schoonheim, Menno Michiel; Steenwijk, Martijn D.; VANZEIR, Ellen; VAN WIJMEERSCH, Bart; Geurts, Jeroen J. G.; FEYS, Peter; Hulst, Hanneke E. | Journal Contribution | A1 |
| 92 | 2019 | Effectiveness and safety of Tetrahydrocannabinol - Cannabidiol Oromucosal spray in Belgian patients with multiple sclerosis spasticity: a retrospective data collection | POPESCU, Veronica; Vos, C.; van Dael, V.; Raeymaekers, G.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 93 | 2019 | Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis | YPERMAN, Jan; BECKER, Thijs; VALKENBORG, Dirk; POPESCU, Veronica; HELLINGS, Niels; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | M |
| 94 | 2019 | Deciphering morphology of Evoked Potentials | YPERMAN, Jan; BECKER, Thijs; VALKENBORG, Dirk; HELLINGS, Niels; Cambron, M.; Dive, D.; Laureys, G.; POPESCU, Veronica; VAN WIJMEERSCH, Bart; PEETERS, Liesbet | Journal Contribution | M |
| 95 | 2018 | Durable Clinical Efficacy of Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study) | Vermersch, Patrick; Coles, Alasdair J.; Boyko, Alexey N.; De Seze, Jerome; Hartung, Hans-Peter; Havrdova, Eva; Inshasi, Jihad Said; McCombe, Pamela; Montalban, Xavier; Pozzilli, Carlo; Selmaj, Krzysztof W.; Margolin, David H.; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 96 | 2018 | Durable Efficacy and Safety With Alemtuzumab in CARE-MS I Patients Switching From SC IFNB-1a: 5-Year Follow-up (TOPAZ Study) | Steingo, Brian; Oreja-Guevara, Celia; Alroughani, Raed; Brassat, David; Boyko, Alexey N.; McCombe, Pamela; VAN WIJMEERSCH, Bart; Margolin, David H.; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.; Vermersch, Patrick | Journal Contribution | M |
| 97 | 2018 | Treatment Experiences of Patients with MS: Results From the Global vs MS (TM) Survey | Bass, Ann; VAN WIJMEERSCH, Bart; Boster, Aaron; Mayer, Lori; Mandel, Matt; Sharrock, Kersten; Mitchell, Colin P.; Singer, Barry | Journal Contribution | M |
| 98 | 2018 | Alemtuzumab Provides Durable Efficacy and Safety Over 5 Years After Switching From SC IFNB-1a: Follow-up of Patients From CARE-MS II (TOPAZ Study) | VAN WIJMEERSCH, Bart; Boyko, Alexey N.; Broadley, Simon; Brassat, David; Dive, Dominique; Hupperts, Raymond M. M.; Lycke, Jan; Montalban, Xavier; Sharrack, Basil; Wray, Sibyl; Margolin, David H.; Chung, Luke; Daizadeh, Nadia; Chirieac, Madalina; Wiendl, Heinz | Journal Contribution | M |
| 99 | 2018 | Determinants of MS re-activation after discontinuing therapies | Husin, H.; Wallace, J.; Malpas, C.; Sharmin, S; Horakova, D.; Havrdova, E. Kubala; Izquierdo, G.; Eichau, S.; Prat, A.; Girard, M.; Duquette, P.; Trojano, M.; Grammond, P.; Lugaresi, A.; Onofrj, M.; Ozakbas, S.; Butzkueven, H.; Sola, P.; Ferraro, D.; Alroughani, R.; Grand'Maison, F.; Terzi, M.; Lechner-Scott, J.; Boz, C.; Hupperts, R.; Shaygannejad, V.; Bergamaschi, R.; Pucci, E.; Van Pesch, V.; Hodgkinson, S.; McCombe, P.; Granella, F.; Slee, M.; VAN WIJMEERSCH, Bart; Karabudak, R.; Prevost, J.; Petersen, T.; Spitaleri, D.; Barnett, M.; Solaro, C.; Iuliano, G.; Verheul, F.; Ramo-Tello, C.; Turkoglu, R.; Fernandez Bolanos, R.; Butler, E.; Macdonell, R.; Soysal, A.; Betancur, M. Moreno; Kalincik, T. | Journal Contribution | M |
| 100 | 2018 | Lack of apparent association between lymphocyte pharmacodynamics and clinical or MRI disease activity in alemtuzumab-treated relapsing-remitting Multiple Sclerosis patients through 6 years: CARE-MS extension | VAN WIJMEERSCH, Bart; Carraro, M.; Comi, G.; Izquierdo, G.; Kim, H. J.; Sharrack, B.; Tornatore, C.; Daizadeh, N.; Melanson, M.; Jacobs, Alessia; Wiendl, H. | Journal Contribution | M |
| 101 | 2018 | Durable suppression of MRI disease activity and slowing of brain volume loss in alemtuzumab-treated patients with active RRMS: 7-year follow-up of CARE-MS I (TOPAZ Study) | Schippling, S.; Arnold, D.; Barnett, M.; Comi, G.; Laganke, C.; Rovira, A.; Traboulsee, A.; Melanson, M.; Daizadeh, N.; Nakamura, K.; VAN WIJMEERSCH, Bart; Pelletier, D. | Journal Contribution | M |
| 102 | 2018 | Lack of apparent association between lymphocyte repopulation kinetics and autoimmune events in alemtuzumab-treated patients with relapsing-remitting Multiple Sclerosis through 6 years: CARE-MS extension | Wiendl, H.; Carraro, M.; Comi, G.; Izquierdo, G.; Kim, H. J.; Sharrack, B.; Tornatore, C.; Daizadeh, N.; Melanson, M.; JACOBS, Andre; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 103 | 2018 | Alemtuzumab provides durable clinical efficacy in patients with active rrms in the absence of continuous treatment: 7-Year follow-up of CARE-MS I (TOPAZ Study) | VAN WIJMEERSCH, Bart; Vermersch, P.; Boyko, A.; de Seze, J.; Hartung, H. -P.; Havrdova, E. Kubala; Inshasi, J. Said; McCombe, P.; Montalban, X.; Pozzili, C.; Melanson, M.; Daizadeh, N.; Rodriguez, C.; Selmaj, K. | Journal Contribution | M |
| 104 | 2018 | Long-term Improvement in Clinical Outcomes in Alemtuzumab-Treated RRMS Patients Who Relapsed Between Courses 1 and 2 (CARE-MS I) | Broadley, S.; Wiendl, Heinz; Fernandez, O.; Freedman, M. S.; Izquierdo, G.; Lycke, J.; Pozzilli, C.; Sharrack, B.; Singer, B. A.; Steingo, B.; Vermersch, P.; Wray, S.; VAN WIJMEERSCH, Bart; Ziemssen, T.; Margolin, D. H.; Thangavelu, K.; Boster, A. | Journal Contribution | M |
| 105 | 2018 | No correlation between lymphocyte repopulation kinetics and MS disease activity following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis | Wiendl, H.; Brandes, D.; Carraro, M.; Comi, G.; Mao-Draayer, Y.; Izquierdo, G.; Kim, H. -J.; Meuth, S.; Pardo, G.; Sharrack, B.; Tornatore, C.; Ziemssen, T.; JACOBS, Andre; Chung, L.; Daizadeh, N.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 106 | 2018 | No correlation between lymphocyte pharmacodynamics and autoimmune adverse events following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis | Wiendl, H.; Brandes, D.; Carraro, M.; Comi, G.; Mao-Draayer, Y.; Izquierdo, G.; Kim, H. -J.; Meuth, S.; Pardo, G.; Sharrack, B.; Tornatore, C.; Ziemssen, T.; Jacobs, Alessia; Chung, L.; Daizadeh, N.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 107 | 2018 | Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study) | VAN WIJMEERSCH, Bart; Barone, D.; Broadley, S.; Dive, D.; Hupperts, R. M. M.; Lycke, J.; Massacesi, L.; Montalban, X.; Naismith, R. T.; Pandey, K.; Schippling, S.; Vermersch, P.; Chung, L.; Daizadeh, N.; Rodriguez, C. E.; Nakamura, K.; Wiendl, H. | Journal Contribution | M |
| 108 | 2018 | DURABLE CLINICAL EFFICACY OF ALEMTUZUMAB IN PATIENTS WITH ACTIVE RRMS IN THE ABSENCE OF CONTINUOUS TREATMENT: 7-YEAR FOLLOW-UP OF CARE-MS I PATIENTS (TOPAZ STUDY) | McCombe, Pamela; Boyko, Alexey N.; DeSeze, Jerome; Hartung, Hans-Peter; Havrdova, Eva; Inshasi, Jihad Said; Montalban, Xavier; Pozzilli, Carlo; Selmaj, Krzysztof W.; Vermersch, Patrick; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E.; VAN WIJMEERSCH, Bart | Journal Contribution | M |
| 109 | 2018 | A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis | Laureys, Guy; Willekens, Barbara; Vanopdenbosch, Ludo; Deryck, Olivier; Selleslag, Dominik; D'Haeseleer, Miguel; De Becker, Ann; Dubois, Benedicte; Dierickx, Daan; Perrotta, Gaetano; De Wilde, Virginie; van Pesch, Vincent; Straetmans, Nicole; Dive, Dominique; Beguin, Yves; VAN WIJMEERSCH, Bart; Theunissen, Koen; Kerre, Tessa; Van de Velde, Ann | Journal Contribution | A1 |
| 110 | 2018 | Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients | MONTES DIAZ, Gwendoline; FRAUSSEN, Judith; VAN WIJMEERSCH, Bart; Hupperts, R.; SOMERS, Veerle | Journal Contribution | A1 |
| 111 | 2018 | Walking endurance and perceived symptom severity after a single maximal exercise test in persons with mild disability because of multiple sclerosis. | MOUMDJIAN, Lousin; GERVASONI, Elisa; VAN HALEWYCK, Florian; OP 'T EIJNDE, Bert; WENS, Inez; VAN GEEL, Fanny; VAN WIJMEERSCH, Bart; FEYS, Peter; VAN ASCH, Paul | Journal Contribution | A1 |
| 112 | 2018 | Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study | D'hooghe, Marie; Van Gassen, Geert; Kos, Daphne; Bouquiaux, Olivier; Cambron, Melissa; Decoo, Danny; Lysandropoulos, Andreas; VAN WIJMEERSCH, Bart; Willekens, Barbara; Penner, Iris-Katharina; Nagels, Guy | Journal Contribution | A1 |
| 113 | 2018 | Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients. | JORISSEN, Winde; VANMIERLO, Tim; WENS, Inez; SOMERS, Veerle; VAN WIJMEERSCH, Bart; BOGIE, Jeroen; Remaley, Alan; OP 'T EIJNDE, Bert; HENDRIKS, Jerome | Journal Contribution | A1 |
| 114 | 2018 | Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done! | PEETERS, Liesbet; van Munster, Caspar E.; VAN WIJMEERSCH, Bart; BRUYNDONCKX, Robin; LAMERS, Ilse; HELLINGS, Niels; POPESCU, Veronica; Thalheim, Christoph; FEYS, Peter | Journal Contribution | A1 |
| 115 | 2017 | Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study. | Costers, Lars; Gielen, Jeroen; Eelen, Piet L.; Van Schependom, Jeroen; Laton, Jorne; Van Remoortel, Ann; VANZEIR, Ellen; VAN WIJMEERSCH, Bart; Seeldrayers, Pierrette; Haelewyck, Marie-Claire; D'Haeseleer, Miguel; D'hooghe, Marie-Beatrice; Langdon, Dawn; Nagels, Guy | Journal Contribution | M |
| 116 | 2017 | Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses | Comi, G.; Boster, A.; Alroughani, R.; Berkovich, R.; Izquierdo, G.; Kantor, D.; Laganke, C.; Limmroth, V.; Macdonell, R.; Moreau, T.; Sharrack, B.; Wiendl, H.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Melanson, M.; Freedman, M. S. | Journal Contribution | M |
| 117 | 2017 | Teri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMS | Wiendl, Heinz; Gross, Catharina C.; Eschborn, Melanie; Weisser, Linda; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Brette, Sandrine; Turner, Timothy J.; Bar-Or, Amit; Klotz, Luisa | Journal Contribution | M |
| 118 | 2017 | Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation | VANHEUSDEN, Marjan; BROUX, Bieke; Welten, Suzanne P. M.; PEETERS, Liesbet; Panagioti, Eleni; VAN WIJMEERSCH, Bart; SOMERS, Veerle; STINISSEN, Piet; Arens, Ramon; HELLINGS, Niels | Journal Contribution | A1 |
| 119 | 2017 | Cytotoxic CD4+T Cells Drive Multiple Sclerosis Progression | PEETERS, Liesbet; VANHEUSDEN, Marjan; SOMERS, Veerle; VAN WIJMEERSCH, Bart; STINISSEN, Piet; BROUX, Bieke; HELLINGS, Niels | Journal Contribution | A1 |
| 120 | 2017 | Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study | Costers, Lars; Gielen, Jeroen; Eelen, Piet L.; van Schependom, Jeroen; Laton, Jorne; Van Remoortel, Ann; VANZEIR, Ellen; VAN WIJMEERSCH, Bart; Seeldrayers, Pierrette; Haelewyck, Marie-Claire; D'Haeseleer, Miguel; D'hooghe, Marie-Beatrice; Langdon, Dawn; Nagels, Guy | Journal Contribution | A1 |
| 121 | 2016 | Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatment | Bermel, R.; Comi, G.; Eralinna, J. -P.; Leist, T. P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Bernasconi, C.; Buffels, R.; Csoboth, C.; Han, J.; Musch, B.; Vermersch, P. | Journal Contribution | M |
| 122 | 2016 | Durable improvement in clinical outcomes in treatmentnaive patients with relapsing-remitting multiple sclerosis who switched from SC IFNB-1a to alemtuzumab (care-MS I extension study 4-year follow-up) | Oreja-Guevara, C.; Alroughani, R.; Brassat, D.; Boyko, A. N.; McCombe, P.; Steingo, B.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Vermersch, P. | Journal Contribution | M |
| 123 | 2016 | Effects of teriflunomide treatment on the CD4(+) T-cell receptor repertoire in patients with relapsing-remitting MS | Klotz, Luisa; Lindner, Maren; Gross, Catherina C.; Eschborn, Melanie; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; Meuth, S. G.; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Maeurer, M.; Stangel, M.; Lang, M.; Tackenberg, B.; Lysandropoulos, A.; Decoo, D.; Eveslage, M.; Turner, Timothy J.; Jagerschmidt, A.; Bar-Or, Amit; Wiendl, Heinz | Journal Contribution | M |
| 124 | 2016 | Durable reduction in MRI disease activity with alemtuzumab in treatment-naive patients with active relapsing-remitting multiple sclerosis: 6-year follow-up of the CARE-MS I study | Arnold, D. L.; Barnett, M.; Comi, G.; Giovannoni, G.; Pelletier, D.; Rovira, A.; Schippling, S.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Traboulsee, A. | Journal Contribution | M |
| 125 | 2016 | Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I). | Coles, A. J.; Boyko, A. N.; Cohen, J. A.; De Seze, J.; Fox, E. J.; Havrdova, E.; Hartung, H. -P.; Inshasi, J. S.; McCombe, P.; Selmaj, K. W.; Vermersch, P.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Rodriguez, C. E.; Montalban, X. | Journal Contribution | M |
| 126 | 2016 | Brain atrophy by automated MRI reading in long-term natalizumab treated patients: Real world data suggests brain atrophy rates in range of healthy individuals | Horakova, Dana; Uher, T.; Vaneckova, M.; Krasensky, J.; Seidl, Z.; van Pesch, V.; Lysandropoulos, A.; VAN WIJMEERSCH, Bart; Ribbens, A.; van Hecke, W.; Dong, Q.; Farkas, M.; Hyde, R.; Koendgen, H. | Journal Contribution | M |
| 127 | 2016 | Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients | CLAES, Nele; FRAUSSEN, Judith; VANHEUSDEN, Marjan; HELLINGS, Niels; STINISSEN, Piet; VAN WIJMEERSCH, Bart; Hupperts, Raymond; SOMERS, Veerle | Journal Contribution | A1 |
| 128 | 2016 | B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses | FRAUSSEN, Judith; CLAES, Nele; VAN WIJMEERSCH, Bart; VAN HORSSEN, Jack; STINISSEN, Piet; Hupperts, Raymond; SOMERS, Veerle | Journal Contribution | A1 |
| 129 | 2016 | Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic Review | LAMERS, Ilse; MARIS, Anneleen; SEVERIJNS, Deborah; Dielkens, Wouter; Geurts, Sander; VAN WIJMEERSCH, Bart; FEYS, Peter | Journal Contribution | A1 |
| 130 | 2016 | Effects of an individual 12 weeks community located running program on physical capacity, walking, cognitive function, dual tasking and brain volumes and structures in persons with Multiple Sclerosis. | FEYS, Peter; MOUMDJIAN, Lousin; Vanhalewyck, F.; WENS, Inez; OP 'T EIJNDE, Bert; VAN WIJMEERSCH, Bart; POPESCU, Veronica; Dufour, A.; Delva, S.; VAN ASCH, Paul | Journal Contribution | M |
| 131 | 2015 | B cells from MS patients induce autoreactive Th1 and Th17 responses | FRAUSSEN, Judith; CLAES, Nele; HELLINGS, Niels; VAN WIJMEERSCH, Bart; STINISSEN, Piet; Hupperts, R.; SOMERS, Veerle | Journal Contribution | M |
| 132 | 2015 | Characterizing the impact of teriflunomide on adaptive immune cell subsets, repertoire and function in patients with relapsing-remitting MS: TERI-DYNAMIC | Wiendl, H.; Gross, C. C.; Lindner, M.; Eschborn, M.; Weisser, L.; Posevitz-Fejfar, A.; Schulte-Mecklenbeck, A.; VAN WIJMEERSCH, Bart; Hupperts, R.; Lunven, C.; Brette, S.; Turner, T. J.; Klotz, L. | Journal Contribution | M |
| 133 | 2015 | Associations of Upper Limb Disability Measures on Different Levels of the International Classification of Functioning, Disability and Health in People With Multiple Sclerosis | LAMERS, Ilse; Cattaneo, Davide; Chen, Christine C.; Bertoni, Rita; VAN WIJMEERSCH, Bart; FEYS, Peter | Journal Contribution | A1 |
| 134 | 2015 | Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis | DHAEZE, Tessa; PEELEN, Evelyn; Hombrouck, Anneleen; PEETERS, Liesbet; VAN WIJMEERSCH, Bart; LEMKENS, Nele; LEMKENS, Peter; SOMERS, Veerle; Lucas, Sophie; BROUX, Bieke; STINISSEN, Piet; HELLINGS, Niels | Journal Contribution | A1 |
| 135 | 2015 | Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis | JANSSENS, Kris; Van den Haute, C.; Baekelandt, Veerle; Lucas, S.; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HELLINGS, Niels; HENDRIKS, Jerome; SLAETS, Leen; SOMERS, Veerle | Journal Contribution | A1 |
| 136 | 2015 | Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations | Gallo, P.; VAN WIJMEERSCH, Bart | Journal Contribution | A1 |
| 137 | 2015 | IL-15 Amplifies the Pathogenic Properties of CD4+CD28- T Cells in Multiple Sclerosis | BROUX, Bieke; Mizee, Mark R.; VANHEUSDEN, Marjan; VAN DER POL, Susanne; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; SOMERS, Veerle; DE VRIES, Helga E.; STINISSEN, Piet; HELLINGS, Niels | Journal Contribution | A1 |
| 138 | 2015 | Optimizing therapy early in multiple sclerosis: An evidence-based view | Ziemssen, Tjalf; De Stefano, Nicola; Sormani, Maria Pia; VAN WIJMEERSCH, Bart; Wiendl, Heinz; Kieseier, Bernd C. | Journal Contribution | A1 |
| 139 | 2015 | Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index | DE BOCK, Laura; FRAUSSEN, Judith; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; VAN WIJMEERSCH, Bart; van Pesch, Vincent; STINISSEN, Piet; SOMERS, Veerle | Journal Contribution | A1 |
| 140 | 2014 | Taking a closer look at Spag16 in multiple sclerosis | DE BOCK, Laura; SOMERS, Klaartje; FRAUSSEN, Judith; HENDRIKS, Jerome; VAN HORSSEN, Jack; ROUWETTE, Myrthe; HELLINGS, Niels; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; Hupperts, Raymond; Jongen, Peter; Damoiseaux, Jan; Verbeek, Marcel M.; De Deyn, Peter P.; D'hooghe, Marie; VAN WIJMEERSCH, Bart; STINISSEN, Piet; SOMERS, Veerle | Journal Contribution | M |
| 141 | 2014 | Leukemia inhibitory factor shifts the immune balance towards regulatory T cells | JANSSENS, Kris; Van den Haute, Chris; Baekelandt, Veerle; VAN HORSSEN, Jack; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HENDRIKS, Jerome; SLAETS, Leen; HELLINGS, Niels | Journal Contribution | M |
| 142 | 2014 | Significant and meaningful improvement in treatment satisfaction with teriflunomide versus subcutaneous ifnb-1A in patients with relapsing ms results from tenere | Maurer, M.; VAN WIJMEERSCH, Bart; de Seze, J.; Meca-Lallana, J.; Bozzi, S.; Vermersch, P. | Journal Contribution | M |
| 143 | 2014 | HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients. | PANNEMANS, Kim; BROUX, Bieke; Goris, An; Dubois, Bénédicte; BROEKMANS, Tom; VAN WIJMEERSCH, Bart; Geraghty, Daniel; STINISSEN, Piet; HELLINGS, Niels | Journal Contribution | A1 |
| 144 | 2014 | Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis | DE BOCK, Laura; SOMERS, Klaartje; FRAUSSEN, Judith; HENDRIKS, Jerome; VAN HORSSEN, Jack; ROUWETTE, Myrthe; HELLINGS, Niels; Villar, Luisa M.; Alvarez-Cermeno, Jose C.; Espino, Mercedes; Hupperts, Raymond; Jongen, Peter; Damoiseaux, Jan; Verbeek, Marcel M.; De Deyn, Peter P.; D'hooghe, Marie; VAN WIJMEERSCH, Bart; STINISSEN, Piet; SOMERS, Veerle | Journal Contribution | A1 |
| 145 | 2014 | Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study | CLAES, Nele; DHAEZE, Tessa; FRAUSSEN, Judith; BROUX, Bieke; VAN WIJMEERSCH, Bart; STINISSEN, Piet; HELLINGS, Niels; SOMERS, Veerle; Hupperts, Raymond | Journal Contribution | A1 |
| 146 | 2014 | Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors | THEWISSEN, Kristof; Nuyts, Amber H.; Deckx, Nathalie; VAN WIJMEERSCH, Bart; Nagels, Guy; D'hooghe, Marie; Willekens, Barbara; Cras, Patrick; OP 'T EIJNDE, Bert; Goossens, Herman; Van Tendeloo, Viggo F. I.; STINISSEN, Piet; Berneman, Zwi N.; HELLINGS, Niels; Cools, Nathalie | Journal Contribution | A1 |
Loading...
5
0
5
0
false